Buprenorphine possesses many unique attributes that make it a practical agent for adults
and adolescents with opioid use disorder (OUD) and/or acute or chronic pain. Sublingual …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …

Background Policy evaluations and health system interventions often utilize International
Classification of Diseases (ICD) codes of opioid use, dependence, and abuse to identify …

Buprenorphine, a novel long-acting analgesic, was developed with the intention of two
purposes: analgesia and opioid use disorder. Regarding its pharmacodynamics, it is a …

Importance Opioid misuse and opioid use disorder (OUD) are important comorbidities in
people with advanced cancer and cancer-related pain, but there is a lack of consensus on …

BACKGROUND: Buprenorphine is a partial agonist at the µ-opioid receptor and an
antagonist at the delta and kappa opioid receptors. It has high affinity and low intrinsic …

Purpose Strategies for deploying clinical pharmacists to increase access to buprenorphine
in inpatient, outpatient and transitional care, and community practice settings are described …

Importance There is a lack of empirical research regarding misuse of buprenorphine
hydrochloride. Objective To identify prescription opioids that are most frequently misused …

Purpose Opioids are highly addictive potent analgesics and anti-allodynics whose use has
dramatically increased in recent decades. The precipitous rise in opioid dependency and …

Long-acting buprenorphine formulations have been recently marketed for the Opioid Agonist
Treatment (OAT) of opioid use disorder (OUD) associated with medical, social, and …